Mathew Sheridan

Diagnostic uncertainty presented barriers to the timely management of acute thrombotic thrombocytopenic purpura in the United Kingdom between 2014 and 2019

Tom Bull, Rory McCulloch, Phillip L.R. Nicolson et al. · Journal of Thrombosis and Haemostasis · 2022 · 22 citations · Full text

Medicine, Emergency Medicine, Hematology +13

Tranexamic acid versus placebo to prevent bleeding in patients with haematological malignancies and severe thrombocytopenia (TREATT): a randomised, double-blind, parallel, phase 3 superiority trial

Lise J Estcourt, Zoe McQuilten, Peter Bardy et al. · The Lancet Haematology · 2024 · 13 citations · Full text

Medicine, Hematology, Pharmacology +13

The small inhibitor WM-1119 effectively targets KAT6A-rearranged AML, but not KMT2A-rearranged AML, despite shared KAT6 genetic dependency

Mathew Sheridan, Muhammad Ahmad Maqbool, Anne Largeot et al. · Journal of Hematology & Oncology · 2024 · 10 citations · Full text

Medicine, Molecular Biology, Molecular Genetics +13